US2009269815A1PendingUtilityA1
Linear amplification of short nucleic acids
Est. expiryMay 31, 2025(expired)· nominal 20-yr term from priority
Inventors:Will Bloch
C12Q 1/6853C12Q 1/6844C12P 19/34
75
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present teachings provide novel methods for amplifying short nucleic acids. In some embodiments, the present teachings provide novel methods for linearly amplifying a collection of micro RNAs by using temperature cycling during a reverse transcription reaction. The cycling can comprise at least 20 cycles of an annealing temperature segment of 10° C.-30° C., and a denaturation temperature segment of 35° C.-60° C. In some embodiments, the temperature cycled reaction can comprise an osmolyte.
Claims
exact text as granted — not AI-modified1 . A method of linearly amplifying a multiplicity of different short nucleic acid sequences, wherein the multiplicity of short nucleic acid sequences are 15-35 nucleotides in length, said method comprising;
forming a reaction mixture comprising a multiplicity of different short nucleic acids, a multiplicity of target-specific primers, and an enzyme that catalyzes target-specific primer extension; annealing the collection of target-specific primers to the multiplicity of different short nucleic acids; extending the multiplicity of target-specific primers with the enzyme that catalyzes target-specific primer extension; cycling the reaction mixture for at least 20 cycles between an annealing temperature segment of 10° C.-30° C., and a denaturation temperature segment of 35° C.-60° C.; and, linearly amplifying the multiplicity of different short nucleic acid sequences.
2 . The method according to claim 1 wherein the multiplicity of different short nucleic acid sequences comprise micro RNAs.
3 . The method according to claim 1 wherein the reverse transcriptase is heat-sensitive, but fails to lose substantial activity in the at least 20 cycles.
4 . The method according to claim 1 wherein the collection of target-specific primers comprise stem-loop primers.
5 . The method according to claim 1 wherein the annealing temperature is 20° C.-30° C.
6 . The method according to claim 1 wherein the annealing temperature is 24° C.-28° C.
7 . The method according to claim 1 wherein the denaturation temperature is 40° C.-50° C.
8 . The method according to claim 1 wherein the denaturation temperature is 42° C.-48° C.
9 . The method according to claim 1 wherein 100-200 cycles are performed.
10 . The method according to claim 1 wherein the annealing segment is 1-2 minutes during each cycle.
11 . The method according to claim 1 wherein the denaturation segment is 2-10 seconds during each cycle.
12 . The method according to claim 1 wherein at least 100 different short nucleic acid sequences are amplified.
13 . The method according to claim 1 wherein the reaction mixture comprises an osmolyte.
14 . The method according to claim 13 wherein the osmolyte is betaine, sorbitol, or glycerol.
15 . The method according to claim 14 wherein the betaine, sorbitol, or glycerol are present in a total concentration of about 2 molar in the reaction mixture.
16 . The method according to claim 1 wherein the enzyme that catalyzes target-specific primer extension is a reverse transcriptase.
17 . The method according to claim 1 wherein the annealing temperature segment is 20° C.-30° C., the denaturation temperature segment of 40° C.-50° C., and at least 50 cycles are performed.
18 . A method of linearly amplifying a short nucleic acid sequence, wherein the short nucleic acid sequence is 15-35 nucleotides in length, said method comprising;
forming a reaction mixture comprising the short nucleic acid, a target-specific primer, and an enzyme that catalyzes target-specific primer extension; annealing the target-specific primer to the short nucleic acid; extending the target-specific primer with the enzyme that catalyzes target-specific primer extension; cycling the reaction mixture for at least 20 cycles between an annealing temperature segment of 10° C.-30° C., and a denaturation temperature segment of 35° C.-60° C.; and, linearly amplifying the short nucleic acid sequence.
19 . The method according to claim 18 wherein the annealing temperature segment is 20° C.-30° C., the denaturation temperature segment of 40° C.-50° C., and at least 50 cycles are performed.
20 . The method according to claim 19 wherein the reaction mixture comprises an osmolyte, and the osmolyte is betaine, sorbitol, or glycerol.Join the waitlist — get patent alerts
Track US2009269815A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.